Clinical Trials on Urinary Bladder Neoplasms in United Kingdom
Total 64126 results
-
Mark DewhirstCompletedTransitional Cell Carcinoma of Bladder | Superficial Bladder CancerUnited States
-
Matthew GalskyBristol-Myers Squibb; Icahn School of Medicine at Mount SinaiCompleted
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
The Methodist Hospital Research InstitutePfizerRecruitingUrothelial Carcinoma BladderUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnBladder Carcinoma | Post-operative PainUnited States
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel
-
SanofiCompletedUrinary Bladder NeoplasmsBelgium, Mexico, Brazil, Chile, Poland, South Africa, Spain, Israel, United States, Argentina, Australia, Canada, France, India, Italy, Netherlands, Russian Federation, Sweden, Turkey
-
Brown UniversityCures Within Reach; Lifespan; Legorreta Cancer Center at Brown UniversityRecruitingUrothelial Carcinoma Bladder | Androgen Receptor PositiveUnited States
-
enGene, Inc.RecruitingSuperficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in SituUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruitingBladder Cancer | Urothelial Carcinoma BladderUnited States
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | Detrusor OveractivityUnited Kingdom
-
Early is Good Inc.RecruitingBladder CancerUnited States
-
Astellas Pharma Europe B.V.CompletedUnderactive BladderJapan, Poland, Germany, Netherlands, Slovakia, United Kingdom
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Ferring PharmaceuticalsRecruitingBladder CancerUnited States
-
University of PittsburghNot yet recruitingQuality of Life | Bladder CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder CancerUnited States
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingBladder CarcinomaUnited States
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
National Cancer Institute (NCI)RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Metastatic Bladder Carcinoma | Advanced Bladder Carcinoma | Advanced Genitourinary System Carcinoma | Metastatic Genitourinary System CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Musculoskeletal Transplant FoundationActive, not recruitingHernia | Bladder CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterAlbert Einstein College of Medicine; Northwell Health; DeltaQuest Foundation,... and other collaboratorsActive, not recruiting
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Ureter Cancer | Urethral CancerUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingStage III Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
ShionogiCompletedHead and Neck Cancer | Esophageal Cancer | Lung Cancer | Mesothelioma | Bladder CancerUnited Kingdom
-
University of California, Los AngelesRecruitingBladder Cancer | Kidney Failure | Bladder, Neurogenic | Bladder DiseaseUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedCervical Cancer | Bladder Cancer | Endometrial Cancer | Vaginal CancerUnited States
-
ImmunityBio, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
Jason R. BrownMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkActive, not recruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Matthew GalskyMerck Sharp & Dohme LLCRecruitingUrothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Localized CancerUnited States
-
Achieve Life SciencesCompletedCarcinoma, Transitional Cell | Ureteral Neoplasms | Urethral Neoplasms | Bladder NeoplasmsUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedBladder CancerUnited States
-
Matthew GalskyNovartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma | Urothelial Carcinoma | Bladder CarcinomaUnited States
-
Noah Hahn, M.D.Hoosier Cancer Research Network; Achieve Life SciencesCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
University of California, IrvineTerminatedCarcinoma, Transitional CellUnited States
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesItaly, Spain, United States, Korea, Republic of, Turkey, Taiwan, Sweden, Czechia, United Kingdom